From April 1, 2023 to June 30, 2023, the company has repurchased 25,032 shares, representing 0.16% for $0.03 million. With this, the company has completed the repurchase of 517,399 shares, representing 3.5% for $0.63 million under the buyback announced on November 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1414 USD | -7.58% | -9.36% | -28.59% |
05-20 | Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.59% | 4.06M | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.